We could soon be approaching a time where personal cancer vaccines can be tailored to fight an individual patient’s tumor. Two early-stage human clinical trials have successfully used computer algorithms to choose the specific tumor cells that must be killed in order to treat the cancer. Using that information, the researchers could develop personalized cancer vaccines for patients. In one clinical trial, two-thirds of patients displayed no recurrence of their cancer 25 months after vaccination.
Personal cancer vaccines successful in first-stage human trials
More of Today's Solutions
Why becoming a regular is good for your mental health and happiness
BY THE OPTIMIST DAILY EDITORIAL TEAM In a culture that celebrates new restaurants, new workouts, new experiences, anything novel, there is something subtle yet ...
Read MoreHydrogenXT secures $900 million to launch 10 zero-carbon hydrogen hubs across...
BY THE OPTMIST DAILY EDITORIAL TEAM In a sign of how quickly the clean energy landscape is evolving, HydrogenXT has secured a $900 million ...
Read MoreThe case for shifting to a four-day workweek for post-pandemic life
At The Optimist Daily, we’re putting a lot of focus on what the world can do after the pandemic to create a healthier, more ...
Read MoreEuropean cities get funding to transform streets with art
A number of European communities will soon have the opportunity to give their roads a little creative flair. The Asphalt Art Initiative Nineteen European ...
Read More
